1
|
Robin J, Albouy M, Jourdain B, Binson G, Sauvaget A, Pierre-Eugène P, Wu L, Migeot V, Dupuis A, Venisse N. Assessment of Endocrine Disruptor Exposure in Hospital Professionals Using Hair and Urine Analyses: An Awareness Campaign. Ther Drug Monit 2024; 46:102-110. [PMID: 37559216 DOI: 10.1097/ftd.0000000000001132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2023] [Accepted: 06/04/2023] [Indexed: 08/11/2023]
Abstract
BACKGROUND In 2021, French public authorities initiated the fourth National Environmental Health Plan to prevent environment-related health risks. This plan primarily focuses on the sensitization of health professionals and health care institutions. Endocrine disruptors (EDs) are environmental factors associated with several adverse health effects, such as reproductive disorders, obesity, and cancer. This study aimed to conduct an awareness campaign among professionals at a general hospital center on the risks related to EDs. METHODS Hospital professionals were directly involved in this study, and urine and hair samples were collected to determine bisphenol and paraben exposure levels. Analyses were performed using validated liquid chromatography-tandem mass spectrometry methods, enabling the simultaneous determination of bisphenols and parabens. A questionnaire on lifestyle habits was distributed to assess its relationship with the exposure profiles. Nineteen professionals were recruited for the study. RESULTS Bisphenol A was detected in 95% of the urine samples, and the chlorinated derivatives of bisphenol A were between 16% and 63%. parabens showed detection frequencies between 37% and 100%, and methylparaben was quantified at an average concentration of 0.45 ± 0.46 ng/mL. In hair samples, bisphenols A, F, and S were detected at 95%-100%, chlorinated derivatives of bisphenol A were detected at 37%-68%, and parabens were detected at 100%. CONCLUSIONS This awareness campaign may encourage health care institutions to adopt a policy of reducing endocrine disruptor exposure among their patients and professionals, who could be educated regarding the risks associated with EDs. Conducting a multicenter study to refine the results herein and establish a dynamic to prevent endocrine disruptor and environmental risks in health care systems would be valuable.
Collapse
Affiliation(s)
- Julien Robin
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
| | - Marion Albouy
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
- School of Medicine and Pharmacy, University of Poitiers, Poitiers; and
| | | | - Guillaume Binson
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
- School of Medicine and Pharmacy, University of Poitiers, Poitiers; and
| | - Alexis Sauvaget
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
| | - Pascale Pierre-Eugène
- INSERM, Clinical Investigation Center 1402
- School of Medicine and Pharmacy, University of Poitiers, Poitiers; and
| | - Luyao Wu
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
| | - Virginie Migeot
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- School of Medicine and Pharmacy, University of Poitiers, Poitiers; and
| | - Antoine Dupuis
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
- School of Medicine and Pharmacy, University of Poitiers, Poitiers; and
| | - Nicolas Venisse
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
| |
Collapse
|
2
|
Cambien G, Dupuis A, Belmouaz M, Bauwens M, Bacle A, Ragot S, Migeot V, Albouy M, Ayraud-Thevenot S. Bisphenol A and chlorinated derivatives of bisphenol A assessment in end stage renal disease patients: Impact of dialysis therapy. Ecotoxicol Environ Saf 2024; 270:115880. [PMID: 38159342 DOI: 10.1016/j.ecoenv.2023.115880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Revised: 09/25/2023] [Accepted: 12/20/2023] [Indexed: 01/03/2024]
Abstract
Patients with end stage kidney disease treated by dialysis (ESKDD) process dialysis sessions to remove molecules usually excreted by kidneys. However, dialysis therapy could also contribute to endocrine disruptors (ED) burden. Indeed, materials like dialyzer filters, ultrapure dialysate and replacement fluid could exposed ESKDD patients to Bisphenol A (BPA) and chlorinated derivatives of BPA (ClxBPAs). Thus, our aim was to compare BPA and ClxBPAs exposure between ESKDD patients, patients with stage 5 chronic kidney disease (CKD5) not dialyzed and healthy volunteers. Then we describe the impact of a single dialysis session, according to dialysis modalities (hemodialysis therapy (HD) versus online hemodiafiltration therapy (HDF)) and materials used with pre-post BPA and ClxBPAs concentrations. The plasma levels of BPA and four ClxBPAs, were assessed for 64 ESKDD patients in pre and post dialysis samples (32 treated by HD and 32 treated by HDF) in 36 CKD5 patients and in 24 healthy volunteers. BPA plasma concentrations were 22.5 times higher for ESKDD patients in pre-dialysis samples versus healthy volunteers (2.208 ± 5.525 ng/mL versus 0.098 ± 0.169 ng/mL) (p < 0.001). BPA plasma concentrations were 16 times higher for CKD5 patients versus healthy volunteers, but it was not significant (1.606 ± 3.230 ng/mL versus 0.098 ± 0.169 ng/mL) (p > 0.05). BPA plasma concentrations for ESKDD patients in pre-dialysis samples were 1.4 times higher versus CKD5 patients (2.208 ± 5.525 ng/mL versus 1.606 ± 3.230 ng/mL) (p < 0.001). For healthy volunteers, ClxBPAs were never detected, or quantified while for CKD5 and ESKDD patients one ClxBPAs at least has been detected or quantified in 14 patients (38.8%) and 24 patients (37.5%), respectively. Dialysis therapy was inefficient to remove BPA either for HD (1.983 ± 6.042 ng/mL in pre-dialysis versus 3.675 ± 8.445 ng/mL in post-dialysis) or HDF (2.434 ± 5.042 ng/mL in pre-dialysis versus 7.462 ± 15.960 ng/mL in post dialysis) regarding pre-post BPA concentrations (p > 0.05). The same result was observed regarding ClxBPA analysis. Presence of polysulfone in dialyzer fibers overexposed ESKDD patients to BPA in pre-dialysis samples with 3.054 ± 6.770 for ESKDD patients treated with a polysulfone dialyzer versus 0.708 ± 0.638 (p = 0.040) for ESKDD patients treated without a polysulfone dialyzer and to BPA in post-dialysis samples with 6.629 ± 13.932 for ESKDD patients treated with a polysulfone dialyzer versus 3.982 ± 11.004 (p = 0.018) for ESKDD patients treated without a polysulfone dialyzer. This work is to our knowledge the first to investigate, the impact of a dialysis session and materials used on BPA and ClxBPAs plasma concentrations and to compare these concentrations to those found in CKD5 patients and in healthy volunteers.
Collapse
Affiliation(s)
- Guillaume Cambien
- Université de Poitiers, CNRS, EBI, F-86000 Poitiers, France; Université de Poitiers, CHU de Poitiers, INSERM, Centre d'investigation Clinique CIC1402, Axe santé Environnementale, Poitiers, France; CHU de Poitiers, Biology-Pharmacy-Public Health Department, F-86000 Poitiers, France.
| | - Antoine Dupuis
- Université de Poitiers, CNRS, EBI, F-86000 Poitiers, France; Université de Poitiers, CHU de Poitiers, INSERM, Centre d'investigation Clinique CIC1402, Axe santé Environnementale, Poitiers, France; CHU de Poitiers, Biology-Pharmacy-Public Health Department, F-86000 Poitiers, France.
| | - Mohamed Belmouaz
- CHU de Poitiers, Digestiv, Urology, Nephrology, Endocrinology Department, F-86000 Poitiers, France.
| | - Marc Bauwens
- CHU de Poitiers, Digestiv, Urology, Nephrology, Endocrinology Department, F-86000 Poitiers, France.
| | - Astrid Bacle
- CHU Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000 Rennes, France; Pôle Pharmacie, Service Hospitalo-Universitaire de Pharmacie, CHU Rennes, 35000, Rennes, France.
| | - Stéphanie Ragot
- Université de Poitiers, CHU de Poitiers, INSERM, Centre d'investigation Clinique CIC1402, Axe SCALE-EPI, Poitiers, France.
| | - Virginie Migeot
- CHU Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000 Rennes, France; CHU Rennes, Epidemiology and Public Health Department, F-35000 Rennes, France.
| | - Marion Albouy
- Université de Poitiers, CNRS, EBI, F-86000 Poitiers, France; Université de Poitiers, CHU de Poitiers, INSERM, Centre d'investigation Clinique CIC1402, Axe santé Environnementale, Poitiers, France; CHU de Poitiers, Biology-Pharmacy-Public Health Department, F-86000 Poitiers, France.
| | - Sarah Ayraud-Thevenot
- Université de Poitiers, CNRS, EBI, F-86000 Poitiers, France; Université de Poitiers, CHU de Poitiers, INSERM, Centre d'investigation Clinique CIC1402, Axe santé Environnementale, Poitiers, France; CHU de Poitiers, Biology-Pharmacy-Public Health Department, F-86000 Poitiers, France.
| |
Collapse
|
3
|
Albouy M, Aubailly S, Jeanneton O, Marteau C, Sobilo L, Boulgana R, Bru G, Bellanger M, Leblanc E, Dos Santos M, Pays K, Choisy P, Bossard E, Nizard C, Thepot A, Gourguillon L, Bulteau AL. Skin-protective biological activities of bio-fermented Aframomum angustifolium extract by a consortium of microorganisms. Front Pharmacol 2023; 14:1303198. [PMID: 38186646 PMCID: PMC10768170 DOI: 10.3389/fphar.2023.1303198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Accepted: 11/29/2023] [Indexed: 01/09/2024] Open
Abstract
Background: Aframomum sp. is a genus of plants in the Zingiberaceae family. It includes several species, some of which are used in cosmetics for their various properties, making them useful in skincare products, particularly for anti-aging, moisturizing, and brightening the skin. However, to date, there is no experimental evidence on its natural extracts obtained or modified using microorganisms (bio-fermentation) as an anti-aging agent. Objective: The present study aimed to evaluate the antiaging effect of a Bio-fermented Aframomum angustifolium (BAA) extract on 3D bioprinted skin equivalent. Methods: The consortium of microorganisms contained Komagataeibacter, Gluconobacter, Acetobacter, Saccharomyces, Torulaspora, Brettanomyces, Hanseniaspora, Leuconostoc, Lactobacillus, Schizosaccharomyces. It was developed on a media containing water, sugar, and infused black tea leaves. The seeds of Aframomum angustifolium previously grounded were mixed with the culture medium, and the ferments in growth; this fermentation step lasted 10 days. Then, the medium was collected and filtered (0.22 µm) to obtain the BAA extract. To enhance our comprehension of the impact of BAA extract on skin aging, we developed skin equivalents using bio-printing methods with the presence or absence of keratinocyte stem cells (KSC). These skin equivalents were derived from keratinocytes obtained from both a middle-aged donor, with and without KSC. Moreover, we examined the effects of treating the KSC-depleted skin equivalents with Bio-fermented Aframomum angustifolium (BAA) extract for 5 days. Skin equivalents containing KSC-depleted keratinocytes exhibited histological characteristics typical of aged skin and were compared to skin equivalents derived from young donors. Results: The BAA extract contained specific organic acids such as lactic, gluconic, succinic acid and polyphenols. KSC-depleted skin equivalents that were treated with BAA extract exhibited higher specular reflection, indicating better hydration of the stratum corneum, higher mitotic activity in the epidermis basal layer, improved dermal-epidermal connectivity, and increased rigidity of the dermal-epidermal junction compared to non-treated KSC-depleted equivalents. BAA extract treatments also resulted in changes at the dermis level, with an increase in total collagen and a decrease in global laxity, suggesting that this extract could help maintain youthful-looking skin. Conclusion: In summary, our findings indicated that BAA extract treatments have pleiotropic beneficial effects on skin equivalents and that the bio-fermentation provides new biological activities to this plant.
Collapse
Affiliation(s)
- Marion Albouy
- LabSkin Creations, Edouard Herriot Hospital, Lyon, France
| | | | | | | | | | | | - Gerard Bru
- LVMH Recherche, Saint Jean de Braye, France
| | | | | | | | - Karl Pays
- LVMH Recherche, Saint Jean de Braye, France
| | | | | | | | - Amelie Thepot
- LabSkin Creations, Edouard Herriot Hospital, Lyon, France
| | | | | |
Collapse
|
4
|
Gonnord T, Clarys D, Dupuy O, Albouy M, Migeot V, Grangeiro R, Esnard C, Boucard G. Effects of combined physical and cognitive program performed in socially enriched environment on older people's cognitive abilities and quality of life (StimCoAPS): study protocol for a randomized controlled trial. BMJ Open Sport Exerc Med 2023; 9:e001577. [PMID: 37860154 PMCID: PMC10582863 DOI: 10.1136/bmjsem-2023-001577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/25/2023] [Indexed: 10/21/2023] Open
Abstract
The number of older people worldwide is constantly increasing. However, ageing is accompanied by a decline in cognitive ability that can affect quality of life. Cognitive, physical and social activities can all slow this decline but social factors and their contribution to the well-being remain under-researched. The aim of this study is to analyse how the practice environment can foster these social relations and thus enhance well-being and to identify the psychological dimensions that are activated by social relations. This study is a 3-year randomised controlled trial designed to assess the effects on participants' cognitive abilities and quality of life of a combined (ie, physical and cognitive) training programme in different social practice environments. A total of 159 older people (≥65 years old) will be recruited and randomly assigned to one of three practice environments: individual practice at home (n=53), group practice in a gymnasium (n=53) and group practice in an enriched environment (n=53). All participants will complete 12-week combined training sessions and will be assessed four times: before the start, in the middle, at the end and 6 months after the end of the programme. They will undergo cognitive function (episodic memory and executive functions), physical capacity (aerobic fitness, muscle strength and dynamic balance) and psychosocial assessments (indicators of psychological well-being, social support, self-esteem, anxiety, depression and achievement goal strategies), as well as semistructured interviews. Statistical analyses will be conducted to assess the effect of the practice environment on the perceived benefits of this programme in terms of cognitive abilities and quality of life, and to determine the role of psychosocial factors in this relationship. This protocol has been approved by an institutional review board (CERSTAPS: IRB00012476-2022-20-01-146). Trials registration number: NCT05721508.
Collapse
Affiliation(s)
- Tiphanie Gonnord
- Centre de Recherches sur la Cognition et l'Apprentissage, Université de Tours, Université de Poitiers, CNRS, Tours, Poitiers, France
| | - David Clarys
- Centre de Recherches sur la Cognition et l'Apprentissage, Université de Tours, Université de Poitiers, CNRS, Tours, Poitiers, France
| | | | - Olivier Dupuy
- Laboratoire Mobilité Vieillissement Exercice, Université de Poitiers, Poitiers, France
| | - Marion Albouy
- INSERM, University Hospital of Poitiers, Clinical Investigation Center (CIC), University de Poitiers, Poitiers, France
- Ecology and Biology of Interactions, CNRS, University of Poitiers, Poitiers, France
- Department of Public Health, BioSPharm Pole, University hospital of Poitiers, Poitiers, France
| | - Virginie Migeot
- INSERM, University Hospital of Poitiers, Clinical Investigation Center (CIC), University de Poitiers, Poitiers, France
- Ecology and Biology of Interactions, CNRS, University of Poitiers, Poitiers, France
- Department of Public Health, BioSPharm Pole, University hospital of Poitiers, Poitiers, France
| | - Rebeca Grangeiro
- Universidade Federal do Cariri, Juazeiro do Norte, Brazil, Brazil
| | - Catherine Esnard
- Centre de Recherches sur la Cognition et l'Apprentissage, Université de Tours, Université de Poitiers, CNRS, Tours, Poitiers, France
| | - Geoffroy Boucard
- Centre de Recherches sur la Cognition et l'Apprentissage, Université de Tours, Université de Poitiers, CNRS, Tours, Poitiers, France
- Laboratoire Mobilité Vieillissement Exercice, Université de Poitiers, Poitiers, France
| |
Collapse
|
5
|
Plattard N, Gnanasegaran R, Krekesheva A, Carato P, Dupuis A, Migeot V, Albouy M, Haddad S, Venisse N. Quantification of the Conjugated Forms of Dichlorobisphenol A (3,3'-Cl 2 BPA) in Rat and Human Plasma Using HPLC-MS/MS. Ther Drug Monit 2023; 45:554-561. [PMID: 36649713 DOI: 10.1097/ftd.0000000000001074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2022] [Accepted: 10/28/2022] [Indexed: 01/19/2023]
Abstract
BACKGROUND Bisphenol A (BPA) is a ubiquitous contaminant that has endocrine-disrupting effects. Chlorinated derivatives of BPA are formed during chlorination of drinking water and have higher endocrine-disrupting activity. Dichlorobisphenol A (Cl 2 BPA) is the most abundant chlorinated BPA derivative found in several human biological matrices. Recent in vitro experiments have shown that Cl 2 BPA is metabolized in sulpho- and glucuro-conjugated compounds. To date, no assay has been developed to quantify the sulfo- and glucuro-conjugates of 3,3'-Cl 2 BPA (3,3'-Cl 2 BPA-S and 3,3'-Cl 2 BPA-G, respectively). METHODS A high-performance liquid chromatography-tandem mass spectrometry assay for the determination of 3,3'-Cl 2 BPA conjugated forms in plasma samples was developed and validated according to the European Medicines Agency guidelines. Quantification was performed in the multiple reaction monitoring mode for all target analytes using a SCIEX 6500 + tandem mass spectrometer with an electrospray source operating in the negative ionization mode. Chromatographic separation was achieved using a C18 column maintained at 40°C and a binary mobile phase delivered in the gradient mode at a flow rate of 0.35 mL/min. Sample was prepared via simple precipitation using acetonitrile. The assay was validated and applied to rat and human plasma samples. RESULTS Linearity was demonstrated over the range of 0.006-25 ng/mL for 3,3'-Cl 2 BPA-G and 0.391-100 ng/mL for 3,3'-Cl 2 BPA-S. Intraday and interday bias values were in the 95%-109% range, and the imprecision <9%. Internal standard corrected matrix effects were also investigated. This method enabled quantification of the conjugated forms of 3,3'-Cl 2 BPA in plasma samples. CONCLUSIONS This is the first report on the development and validation of an analytical method for the quantification of 3,3'-Cl 2 BPA-G and 3,3'-Cl 2 BPA-S in the plasma matrix. This study is also the first report on the in vivo occurrence of these metabolites.
Collapse
Affiliation(s)
- Noemie Plattard
- Department of Environmental and Occupational Health, School of Public Health, CresP, Université de Montréal, Montreal, Quebec, Canada
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
| | - Riciga Gnanasegaran
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
| | - Aida Krekesheva
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
| | - Pascal Carato
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
| | - Antoine Dupuis
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
- Biology-Pharmacy-Public Health Department, CHU de Poitiers, Poitiers Cedex, France
| | - Virginie Migeot
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
- Biology-Pharmacy-Public Health Department, CHU de Poitiers, Poitiers Cedex, France
| | - Marion Albouy
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
- Biology-Pharmacy-Public Health Department, CHU de Poitiers, Poitiers Cedex, France
| | - Sami Haddad
- Department of Environmental and Occupational Health, School of Public Health, CresP, Université de Montréal, Montreal, Quebec, Canada
| | - Nicolas Venisse
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
- Biology-Pharmacy-Public Health Department, CHU de Poitiers, Poitiers Cedex, France
| |
Collapse
|
6
|
Albouy M, Deceuninck Y, Migeot V, Doumas M, Dupuis A, Venisse N, Engene PP, Veyrand B, Geny T, Marchand P, Le Bizec B, Bichon E, Carato P. Characterization of pregnant women exposure to halogenated parabens and bisphenols through water consumption. J Hazard Mater 2023; 448:130945. [PMID: 36758432 DOI: 10.1016/j.jhazmat.2023.130945] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Revised: 12/29/2022] [Accepted: 02/03/2023] [Indexed: 06/18/2023]
Abstract
Exposure of pregnant women to endocrine disruptor compounds, such as parabens and bisphenol A is of concern for fetal transition. Their halogenated degradation products, mainly coming from water treatment plans, could be problematic as well, depending on their occurrence in drinking water in the first place. Thus, 25 halogenated compounds were synthesised in order to investigate 60 substances (Bisphenols, parabens and their degradation products) in 325 drinking water samples coming from a French cohort study of pregnant women. Analysis was performed by tandem mass spectrometry coupled to gas chromatography (GC-MS/MS) after SPE extraction and derivation of the contaminants. Results indicate that parabens (methylparaben, n-propylparaben, ethylparaben and n-butylparaben), bisphenols S, A and F, and their degradation product, 4-hydroxybenzoic acid, were detected up to several hundred ng/L in drinking water, with detection frequencies between 16% and 88%. Regarding halogenated degradation products, the highest detection frequencies were found for monochlorinated products (about 50% for 2-chlorobisphenol A), which were quantified up to several tens of ng/L. Such analytical approaches with broader spectrum of monitoring (i.e. chemical hazards and their degradation products) constitute in the beginning of a solution to exhaustively answer the questions related to the characterization of the human chemical exposome.
Collapse
Affiliation(s)
- Marion Albouy
- Université de Poitiers, F-86000 Poitiers, France; Pole Biospharm Service de Santé Publique, CHU, Poitiers, France; CIC INSERM 1402, UFR Médecine Pharmacie, Poitiers, France.
| | | | - Virginie Migeot
- Université de Poitiers, F-86000 Poitiers, France; Pole Biospharm Service de Santé Publique, CHU, Poitiers, France; CIC INSERM 1402, UFR Médecine Pharmacie, Poitiers, France.
| | - Manon Doumas
- Université de Poitiers, F-86000 Poitiers, France; CIC INSERM 1402, UFR Médecine Pharmacie, Poitiers, France; IC2MP, CNRS 7285, UFR Médecine Pharmacie, Poitiers, France.
| | - Antoine Dupuis
- Université de Poitiers, F-86000 Poitiers, France; CIC INSERM 1402, UFR Médecine Pharmacie, Poitiers, France; Service de Pharmacie, CHU, Poitiers, France.
| | - Nicolas Venisse
- Université de Poitiers, F-86000 Poitiers, France; CIC INSERM 1402, UFR Médecine Pharmacie, Poitiers, France; Service de Toxicologie et Pharmacocinétique, CHU, Poitiers, France.
| | - Pascale Pierre Engene
- Université de Poitiers, F-86000 Poitiers, France; CIC INSERM 1402, UFR Médecine Pharmacie, Poitiers, France.
| | | | - Thomas Geny
- Oniris, INRAE, LABERCA, 44307 Nantes, France.
| | | | | | | | - Pascal Carato
- Université de Poitiers, F-86000 Poitiers, France; CIC INSERM 1402, UFR Médecine Pharmacie, Poitiers, France.
| |
Collapse
|
7
|
Monchaud C, Villeneuve C, Belaiche S, Charbit M, Colosio C, Houssel P, Meurette A, Nubret K, Tissot A, Albouy M, Esposito L. French Recommendations for a National Competency Framework of Therapeutic Patient Education in Solid Organ Transplantation. Transplantation 2023; 107:549-553. [PMID: 36808841 DOI: 10.1097/tp.0000000000004354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Affiliation(s)
- Caroline Monchaud
- Service de Pharmacologie, Toxicologie et Pharmacovigilance, CHU Limoges, Limoges, France
- INSERM UMR-1248 Pharmacologie & Transplantation, Limoges, France
| | - Claire Villeneuve
- INSERM UMR-1248 Pharmacologie & Transplantation, Limoges, France
- Unité de Vigilance des Essais Cliniques, CHU Limoges, Limoges, France
| | - Stéphanie Belaiche
- Institut de Pharmacie, CHU Lille, Lille, France
- Service d'Hépatologie-Transplantation, CHU Lille, Lille, France
| | - Marina Charbit
- Service de Néphrologie Pédiatrique, Hôpital Necker-Enfants Malades, APHP, Paris, France
| | | | | | - Aurélie Meurette
- Service de Néphrologie et Immunologie Clinique, CHU Nantes, Nantes, France
| | - Karine Nubret
- Service de Traitement de l'insuffisance Cardiaque, CHU Bordeaux, Bordeaux, France
| | | | - Marion Albouy
- Ecology and Biology of Interaction Lab, CNRS UMR 7267, University of Poitiers, Poitiers, France
- Clinical Centre for Investigation, INSERM 1402, CHU Poitiers, Poitiers, France
- BioSPharm Pole, Public Health department, CHU Poitiers, Poitiers, France
| | - Laure Esposito
- Département de Néphrologie, Dialyse et Transplantation D'organes, CHU Toulouse, Toulouse, France
| |
Collapse
|
8
|
Lejeune F, Albouy M, Forestier S, Thépot A, Gendronneau G, Dos Santos M. 524 Tissue-engineered human skin age spot model with individualized hyperpigmentation lesion through high-resolution patterned 3D bioprinting and its use for the evaluation of cosmetic ingredients. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.09.539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
9
|
Albouy M, Parthenay M, Nogues M, Leyris A, Degorce L, Barthelemy Z, Rafidison D, Gourgues AS, Migeot V, Pylouster J, Dupuis A. A Clinical Preventive Strategy Based on a Digital Tool to Improve Access to Endocrine Disruptors Exposure Prevention: The MEDPREVED Study. Int J Environ Res Public Health 2022; 19:11993. [PMID: 36231296 PMCID: PMC9565443 DOI: 10.3390/ijerph191911993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Revised: 09/15/2022] [Accepted: 09/16/2022] [Indexed: 06/16/2023]
Abstract
Introduction: The digitalized PREVED (PREgnancy, PreVention, Endocrine Disruptor) questionnaire was used in the clinical practices of health professionals (HP) who adhered to the MEDPREVED strategy. The objectives were to assess the strategy and to determine if it could improve access to endocrine disruptor (ED) exposure prevention. Methods: After having filled in the digital questionnaire in HP waiting rooms, patients were invited to talk about ED exposure during the consultation. HPs were previously trained in ED and had received a prevention kit for their patients. After the seven-month implementation phase, the evaluation phase consisted of five mixed assessments: interviews with: (i) patients who were young children's parents; (ii) patients in the general population; (iii) paediatricians; (iv) midwives; and a quantitative study on GPs. Assessment concerned feasibility, accessibility, and usefulness of the strategy; we then used the Levesque model to evaluate how it could improve access to ED exposure prevention. Results: The study included 69 participants. The strategy appeared feasible for the filling-out step due to digital and environment access. However, it depended on patient and HP profiles. The strategy seemed useful insofar as it facilitated reflexive investment, an intention to healthy behaviour and, rather rarely, talk about ED exposure. The beginning of this discussion depended on time, prioritizing of the topic and HP profile. The strategy has confirmed the Levesque model's limiting factors and levers to access ED prevention. Conclusions: The MEDPREVED strategy is feasible, accessible, and useful in clinical prevention practice. Further study is needed to measure the impact on knowledge, risk perception and behavior of beneficiaries of the MEDPREVED strategy in the medium and long term.
Collapse
Affiliation(s)
- Marion Albouy
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France
- Ecology and Biology of Interaction, CNRS UMR 7267, CEDEX, 86073 Poitiers, France
- INSERM-CIC1402, University Hospital of Poitiers, 2 Rue de la Milétrie, CEDEX, 86021 Poitiers, France
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, CEDEX, 86021 Poitiers, France
| | - Maud Parthenay
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France
| | - Maeva Nogues
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France
| | - Agathe Leyris
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France
| | - Léa Degorce
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France
| | - Zacharie Barthelemy
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France
| | - Diana Rafidison
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France
| | - Anne-Sophie Gourgues
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, CEDEX, 86021 Poitiers, France
| | - Virginie Migeot
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France
- Ecology and Biology of Interaction, CNRS UMR 7267, CEDEX, 86073 Poitiers, France
- INSERM-CIC1402, University Hospital of Poitiers, 2 Rue de la Milétrie, CEDEX, 86021 Poitiers, France
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, CEDEX, 86021 Poitiers, France
| | - Jean Pylouster
- Research Centre on Cognition and Learning, MSHS, 5 Rue T. Lefebvre, CEDEX, 86073 Poitiers, France
| | - Antoine Dupuis
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86000 Poitiers, France
- Ecology and Biology of Interaction, CNRS UMR 7267, CEDEX, 86073 Poitiers, France
- INSERM-CIC1402, University Hospital of Poitiers, 2 Rue de la Milétrie, CEDEX, 86021 Poitiers, France
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, CEDEX, 86021 Poitiers, France
| |
Collapse
|
10
|
Robin J, Binson G, Albouy M, Sauvaget A, Pierre-Eugène P, Migeot V, Dupuis A, Venisse N. Analytical method for the biomonitoring of bisphenols and parabens by liquid chromatography coupled to tandem mass spectrometry in human hair. Ecotoxicol Environ Saf 2022; 243:113986. [PMID: 36027714 DOI: 10.1016/j.ecoenv.2022.113986] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2022] [Revised: 07/05/2022] [Accepted: 08/14/2022] [Indexed: 05/22/2023]
Abstract
Bisphenols and parabens are endocrine disruptors families widely used in daily life. They are known to be linked to numerous pathologies such as reproductive disorders, obesity, breast cancer, hypertension and asthma. Biomonitoring is an essential tool for assessing population exposure to environmental pollutants. Blood and urine are the main matrices used in human biomonitoring. However, they are not suitable to evaluate long-term exposure to endocrine disruptors with a short elimination half-life such as parabens or phenols. Hair appears to be an interesting alternative matrix allowing a wide window of exposure due to an accumulation of xenobiotics during hair growth. This study presents the development and validation of a high-performance liquid chromatography coupled to tandem mass spectrometry for the simultaneous determination of bisphenol A, its chlorinated derivatives, bisphenol F, bisphenol S and parabens in human hair. An optimised sample preparation based on acidic hydrolysis followed by liquid-liquid extraction was performed, before an analysis by ultra-high performance liquid chromatography coupled to tandem mass spectrometry in multiple reaction monitoring mode. To validate the method, recognized bioanalytical guidelines were used and calibration and quality control samples were prepared in human hair samples. Linearities were over 0.996 in the whole range of concentrations. Trueness and precision were demonstrated for each target analyte with intra-day and inter-day bias values ranging from 86 % to 118 % and relative standard deviation values ranging from 0 % to 19 %. At the same time, limits of quantification were set at 0.25 ng/g for bisphenol A and parabens, 0.05 ng/g for bisphenols F and S and 0.00625 ng/g for the chlorinated derivatives of bisphenol A. This reliable method was applied to hair samples taken from hospital professionals and allowed the quantification of these endocrine disruptors in this population. Chlorinated derivatives of bisphenol A were quantified here in hair for the first time.
Collapse
Affiliation(s)
- Julien Robin
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Guillaume Binson
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Marion Albouy
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Alexis Sauvaget
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Pascale Pierre-Eugène
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Virginie Migeot
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Antoine Dupuis
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Nicolas Venisse
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France.
| |
Collapse
|
11
|
Cambien G, Dupuis A, Belmouaz M, Bauwens M, Bacle A, Ragot S, Albouy M, Migeot V, Ayraud-Thevenot S. Exposition des patients dialysés au Bisphénol A : impact du traitement par hémodialyse. Nephrol Ther 2022. [DOI: 10.1016/j.nephro.2022.07.231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
12
|
Migeot V, Guihenneuc J, Ouazzani HE, Albouy M, Dupuis A, Rabouan S. Risk and asset-based strategies in health: priorities in biomedical, life and environmental science literature since the early twentieth century. A rapid review. Environ Health 2022; 21:22. [PMID: 35093075 PMCID: PMC8800416 DOI: 10.1186/s12940-022-00833-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2021] [Accepted: 01/12/2022] [Indexed: 06/14/2023]
Abstract
BACKGROUND In biomedical, life or environmental science research, two different strategies exist depending on the starting point of the researchers: "what makes us ill? " or "what makes us healthy?". Indeed, a risk-based strategy (RBS) attempts to minimize risk factors increasing the likelihood of developing a disease, while an asset-based strategy (ABS) attempts to promote and strengthen the factors that support good health and wellbeing. We provided an up-to-date overview of both research strategies in peer-reviewed scientific literature, in the fields of human health, animal and plant health and ecosystem health, to fit with the One Health framework. More particularly, we focused on human health by studying publications related to the COVID-19 at the beginning of the pandemic. DESIGN A rapid review of research science literature was carried out to identify in the PubMed/MEDLINE database the proportion of peer-reviewed articles adopting either a RBS or an ABS, in the main global environment fields from January 01, 1900 to December 31, 2019 and, related to COVID-19, from December 1, 2019 to May 31, 2020. RESULTS The number of published articles resulting from our search was 1,957,905, including 91.3% with an RBS and 8.7% with an ABS. When examining each field, we found that only 10.5% of human health articles deal with ABS, 5.5% for animal health, 2.2% for ecosystem health, 1.0% for plant health and 2.7% for environmental media. We noted that articles adopting both strategies were published in all health fields. Among the articles concerning COVID-19, 5,854 (55.9%), 542 articles (5.2%) adopted RBS and ABS, respectively, while 4069 (38.9%) simultaneously presenting both strategies. CONCLUSION Our results have allowed us to take stock of the biomedical research strategies prioritized during the twentieth century. It seems highly likely that the two strategies we have analyzed can now be chosen in such a way as to promote a balance in public health measures, at every level to guide One Health interventions aimed at helping people, animals, and plants to lead healthier lives.
Collapse
Affiliation(s)
- Virginie Migeot
- School of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, TSA 51115, 86073, Poitiers Cedex, France
- Clinical Investigation Center, INSERM, 2 rue de la Milétrie 1402, 86021, Poitiers, France
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers, France
- University of Poitiers, CNRS UMR7267, Ecologie & Biologie des Interactions, 86000, Poitiers, France
| | - Jérémy Guihenneuc
- School of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, TSA 51115, 86073, Poitiers Cedex, France
- Clinical Investigation Center, INSERM, 2 rue de la Milétrie 1402, 86021, Poitiers, France
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers, France
- University of Poitiers, CNRS UMR7267, Ecologie & Biologie des Interactions, 86000, Poitiers, France
| | - Houria El Ouazzani
- School of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, TSA 51115, 86073, Poitiers Cedex, France
- Clinical Investigation Center, INSERM, 2 rue de la Milétrie 1402, 86021, Poitiers, France
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers, France
| | - Marion Albouy
- School of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, TSA 51115, 86073, Poitiers Cedex, France
- Clinical Investigation Center, INSERM, 2 rue de la Milétrie 1402, 86021, Poitiers, France
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers, France
- University of Poitiers, CNRS UMR7267, Ecologie & Biologie des Interactions, 86000, Poitiers, France
| | - Antoine Dupuis
- School of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, TSA 51115, 86073, Poitiers Cedex, France
- Clinical Investigation Center, INSERM, 2 rue de la Milétrie 1402, 86021, Poitiers, France
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 rue de la Milétrie, 86021, Poitiers, France
- University of Poitiers, CNRS UMR7267, Ecologie & Biologie des Interactions, 86000, Poitiers, France
| | - Sylvie Rabouan
- School of Medicine and Pharmacy, University of Poitiers, 6 rue de la Milétrie, TSA 51115, 86073, Poitiers Cedex, France
- Clinical Investigation Center, INSERM, 2 rue de la Milétrie 1402, 86021, Poitiers, France
- University of Poitiers, CNRS UMR7267, Ecologie & Biologie des Interactions, 86000, Poitiers, France
| |
Collapse
|
13
|
Desanlis A, Albouy M, Rousselle P, Thépot A, Santos MD, Auxenfans C, Marquette C. Validation of an implantable bioink using mechanical extraction of human skin cells: First steps to a 3D bioprinting treatment of deep second degree burn. J Tissue Eng Regen Med 2020; 15:37-48. [PMID: 33170542 DOI: 10.1002/term.3148] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2020] [Revised: 10/16/2020] [Accepted: 10/19/2020] [Indexed: 11/12/2022]
Abstract
Clinical grade cultured epithelial autograft (CEA) are routinely used to treat burns covering more than 60% of the total body surface area. However, although the epidermis may be efficiently repaired by CEA, the dermal layer, which is not spared in deep burns, requires additional treatment strategies. Our aim is to develop an innovative method of skin regeneration based on in situ 3D bioprinting of freshly isolated autologous skin cells. We describe herein bioink formulation and cell preparation steps together with experimental data validating a straightforward enzyme-free protocol of skin cell extraction. This procedure complies with both the specific needs of 3D bioprinting process and the stringent rules of good manufacturing practices. This mechanical extraction protocol, starting from human skin biopsies, allows harvesting a sufficient amount of both viable and growing keratinocytes and fibroblasts. We demonstrated that a dermis may be reconstituted in vitro starting from a medical grade bioink and mechanically extracted skin cells. In these experiments, proliferation of the extracted cells can be observed over the first 21 days period after 3D bioprinting and the analysis of type I collagen exhibited a de novo production of extracellular matrix proteins. Finally, in vivo experiments in a murine model of severe burn provided evidences that a topical application of our medical grade bioink was feasible and well-tolerated. Overall, these results represent a valuable groundwork for the design of future 3D bioprinting tissue engineering strategies aimed at treating, in a single intraoperative step, patients suffering from extended severe burns.
Collapse
Affiliation(s)
- Adeline Desanlis
- Hospices Civils de Lyon, Banque de Tissus et Cellules, Groupement Hospitalier Edouard Herriot, Lyon, France
| | - Marion Albouy
- LabSkin Creations, Edouard Herriot Hospital, Lyon, France
| | - Patricia Rousselle
- Laboratoire de Biologie Tissulaire et Ingénierie Thérapeutique, UMR 5305, CNRS - Université Lyon 1, Institut de Biologie et Chimie des Protéines, SFR BioSciences Gerland-Lyon Sud, Lyon, France
| | - Amélie Thépot
- LabSkin Creations, Edouard Herriot Hospital, Lyon, France
| | | | - Céline Auxenfans
- Hospices Civils de Lyon, Banque de Tissus et Cellules, Groupement Hospitalier Edouard Herriot, Lyon, France.,Laboratoire de Biologie Tissulaire et Ingénierie Thérapeutique, UMR 5305, CNRS - Université Lyon 1, Institut de Biologie et Chimie des Protéines, SFR BioSciences Gerland-Lyon Sud, Lyon, France
| | - Christophe Marquette
- 3d.FAB, Univ Lyon, Université Lyon 1, CNRS, INSA, CPE-Lyon, ICBMS, UMR 5246, Villeurbanne, France
| |
Collapse
|
14
|
Gervason S, Napoli M, Dreux-Zhiga A, Lazzarelli C, Garcier S, Briand A, Albouy M, Thepot A, Berthon JY, Filaire E. Attenuation of negative effects of senescence in human skin using an extract from Sphingomonas hydrophobicum: development of new skin care solution. Int J Cosmet Sci 2019; 41:391-397. [PMID: 31032993 DOI: 10.1111/ics.12534] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2019] [Accepted: 04/23/2019] [Indexed: 11/29/2022]
Abstract
OBJECTIVE Intrinsic skin ageing is mainly caused by cellular senescence. p16 and p21 are two important tumour suppressor proteins that play essential roles during cell proliferation and ageing through regulating the expression of several genes. Moreover, physical changes between the ages of 55 and 60 years affect one's physical and disrupt self-esteem. The cosmetics industry has focused on bioactive substances derived from natural products such as plants, mushrooms and marine algae to counteract the deleterious effect on skin senescence. Besides these products, compounds produced by bacteria may decelerate individual senescence. METHODS In order to evaluate the potential benefits of bacteria extract over skin ageing, we investigated whether a Sphingomonas hydrophobicum (SH) extract is able to protect our skin against senescence mechanisms. We used an ageing full-thickness skin equivalent model, which was treated or not with the bacteria extract in a systemic way for 42 days. p21 and p16 and senescence-associated galactosidase activity were used to detect cellular senescence with immunohistology. Using a psychobiological approach, we evaluated in vivo the effect of SH extract on self-esteem, isotropy and suppleness. RESULTS Sphingomonas extract significantly suppressed senescence associated with β-galactosidase activation. It also significantly inhibited the expression of cell cycle inhibitors (p21 and p16). At the same time, the bacteria extract has a significant positive impact on the issue by increasing the expression of versican and fibrillin-1. Significant improvements of self-esteem were reported after 56 days of SH extract application. These psychological benefits were accompanied by a significant improvement in skin suppleness and isotropy. CONCLUSION Sphingomonas extract delays intrinsic skin ageing process by inhibiting cellular senescence, and has also the capability to restructure the skin. These beneficial physiological effects induced by SH extract have a positive influence on self-esteem. Because skin ageing causes emotional distress, SH extract can serve as an anti-ageing cosmeceutical agent and help to build a better psychological health, and help individuals to assume ageing.
Collapse
Affiliation(s)
- S Gervason
- GREENTECH SA, Biopôle Clermont-Limagne, 63360, Saint-Beauzire, France
| | - M Napoli
- GREENTECH SA, Biopôle Clermont-Limagne, 63360, Saint-Beauzire, France
| | - A Dreux-Zhiga
- GREENTECH SA, Biopôle Clermont-Limagne, 63360, Saint-Beauzire, France
| | - C Lazzarelli
- Deinove, 1682 rue de la Valsiere, 34790, Grabels, France
| | - S Garcier
- Deinove, 1682 rue de la Valsiere, 34790, Grabels, France
| | - A Briand
- Deinove, 1682 rue de la Valsiere, 34790, Grabels, France
| | - M Albouy
- Labskin Creations, Hôpital Edouard Herriot Bâtiment, 5 Place d'Arsonval, 69003, Lyon, France
| | - A Thepot
- Labskin Creations, Hôpital Edouard Herriot Bâtiment, 5 Place d'Arsonval, 69003, Lyon, France
| | - J Y Berthon
- GREENTECH SA, Biopôle Clermont-Limagne, 63360, Saint-Beauzire, France
| | - E Filaire
- GREENTECH SA, Biopôle Clermont-Limagne, 63360, Saint-Beauzire, France.,INRA, UNH, Unité de Nutrition Humaine, CRNH Auvergne, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France
| |
Collapse
|
15
|
Heraud S, Liu X, Thepot A, Liu G, Boher A, Albouy M, Tang J, Che B, Damour O. 1212 Lilium Candidum leaf extract prevents Ultraviolet B-induced pigmentation in an engineered skin model by down-regulating KIT and LEF1 expression. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.1227] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
16
|
Pourchet LJ, Thepot A, Albouy M, Courtial EJ, Boher A, Blum LJ, Marquette CA. Human Skin 3D Bioprinting Using Scaffold-Free Approach. Adv Healthc Mater 2017; 6. [PMID: 27976537 DOI: 10.1002/adhm.201601101] [Citation(s) in RCA: 170] [Impact Index Per Article: 24.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2016] [Revised: 11/15/2016] [Indexed: 01/17/2023]
Abstract
Organ in vitro synthesis is one of the last bottlenecks between tissue engineering and transplantation of synthetic organs. Bioprinting has proven its capacity to produce 3D objects composed of living cells but highly organized tissues such as full thickness skin (dermis + epidermis) are rarely attained. The focus of the present study is to demonstrate the capability of a newly developed ink formulation and the use of an open source printer, for the production of a really complete skin model. Proofs are given through immunostaining and electronic microscopy that the bioprinted skin presents all characteristics of human skin, both at the molecular and macromolecular level. Finally, the printability of large skin objects is demonstrated with the printing of an adult-size ear.
Collapse
Affiliation(s)
- Léa J. Pourchet
- 3d.FAB, Univ Lyon; Université Lyon1; CNRS, INSA, CPE-Lyon; ICBMS; UMR 5246, 43, Bd du 11 novembre 1918 69622 Villeurbanne cedex France
| | - Amélie Thepot
- LabSkin Creations; Edouard Herriot Hospital; 5 place d'Arsonval, Bâtiment 5 69437 Lyon France
| | - Marion Albouy
- LabSkin Creations; Edouard Herriot Hospital; 5 place d'Arsonval, Bâtiment 5 69437 Lyon France
| | - Edwin J. Courtial
- 3d.FAB, Univ Lyon; Université Lyon1; CNRS, INSA, CPE-Lyon; ICBMS; UMR 5246, 43, Bd du 11 novembre 1918 69622 Villeurbanne cedex France
| | - Aurélie Boher
- LabSkin Creations; Edouard Herriot Hospital; 5 place d'Arsonval, Bâtiment 5 69437 Lyon France
| | - Loïc J. Blum
- 3d.FAB, Univ Lyon; Université Lyon1; CNRS, INSA, CPE-Lyon; ICBMS; UMR 5246, 43, Bd du 11 novembre 1918 69622 Villeurbanne cedex France
| | - Christophe A. Marquette
- 3d.FAB, Univ Lyon; Université Lyon1; CNRS, INSA, CPE-Lyon; ICBMS; UMR 5246, 43, Bd du 11 novembre 1918 69622 Villeurbanne cedex France
| |
Collapse
|
17
|
Nandivada H, Montoya J, Flaherty P, Albouy M, Onteniente B, Maruotti J, Saxena D. Long-Term Single-Cell Culture of Human Pluripotent Stem Cells on Precoated rLaminin-521 Cultureware in Multiple Culture Media. Cytotherapy 2016. [DOI: 10.1016/j.jcyt.2016.03.250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
18
|
Fontaine E, Mir F, Vannier F, Gérardin A, Albouy M, Navarro C, Fontbonne A. Erratum to “Induction of fertile oestrus in the bitch using Deslorelin, a GnRH agonist”. Theriogenology 2014. [DOI: 10.1016/j.theriogenology.2012.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
19
|
Fontaine E, Mir F, Vannier F, Gérardin A, Albouy M, Navarro C, Fontbonne A. Induction of fertile oestrus in the bitch using Deslorelin, a GnRH agonist. Theriogenology 2011; 76:1561-6. [PMID: 21872318 DOI: 10.1016/j.theriogenology.2011.06.031] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2011] [Revised: 06/20/2011] [Accepted: 06/25/2011] [Indexed: 11/28/2022]
Abstract
Oestrus induction in various canine breeds was attempted in 32 bitches. A group of 8 bitches were treated 80-160 d following their previous oestrus (G1) whereas a second group of 24 bitches (G2) were implanted 200-590 d following their previous oestrus. The treatment for each bitch consisted in one Deslorelin implant (Suprelorin® 4,7 mg, Virbac, France), inserted subcutaneously in the post-umbilical region. Ovulation, pregnancy rate and litter size were recorded. All bitches came in heat 4.3 ± 1.4 d after implantation (2-7 d). Ovulation was reported in 62.5% in G1 and 87.5% in G2. One bitch refused mating and since no AI was performed, she was not considered for further analysis. Pregnancy was obtained in 25% in G1 versus 78.3% in G2. Mean litter size was 6.7 ± 3.5 puppies (1-14). Luteal failure was suspected in 3 bitches, two that remained non-pregnant and one which aborted 58 d post-ovulation since the owner refused progesterone supplementation. Deslorelin implants can therefore be considered as a valuable alternative to induce fertile oestrus in bitches in anoestrus. Follow-up of the luteal phase is recommended, since some bitches might encounter luteal failure.
Collapse
Affiliation(s)
- E Fontaine
- Centre d'Etudes en Reproduction des Carnivores (CERCA), Ecole Nationale Vétérinaire d'Alfort, Paris, France.
| | | | | | | | | | | | | |
Collapse
|
20
|
Albouy M, Sanquer A, Maynard L, Eun HM. Efficacies of osaterone and delmadinone in the treatment of benign prostatic hyperplasia in dogs. Vet Rec 2008; 163:179-83. [DOI: 10.1136/vr.163.6.179] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- M. Albouy
- Research and Development Department; Virbac, BP 27 06511 Carros Cedex France
| | - A. Sanquer
- Research and Development Department; Virbac, BP 27 06511 Carros Cedex France
| | - L. Maynard
- Research and Development Department; Virbac, BP 27 06511 Carros Cedex France
| | - H. M. Eun
- Research and Development Department; Virbac, BP 27 06511 Carros Cedex France
| |
Collapse
|
21
|
Badin J, Rousselet F, Albouy M. [Normal and abnormal interactions of gamma-G-globulins with iodine]. Pathol Biol 1966; 14:670-81. [PMID: 4161086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
22
|
Cabau N, Albouy M, Badin J. [Localization of antistreptokinase in the range of immunoproteins]. Ann Biol Clin (Paris) 1966; 24:697-702. [PMID: 4160936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|